Selective effects of the endogenous cannabinoid arachidonylethanolamide (anandamide) on regional cerebral blood flow in the rat

Neuropsychopharmacology

Volumn 19, Issue 6, 1998, Pages 481-491

  Stein, Elliot A ^a   Fuller, Scott A ^a   Edgemond, William S ^a   Campbell, William B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Anandamide; Endogenous cannabinoid; Mesolimbic pathways; Regional cerebral blood flow

Indexed keywords

ANANDAMIDE; CANNABINOID RECEPTOR;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; BRAIN BLOOD FLOW; CAUDATE NUCLEUS; CINGULATE GYRUS; CONTROLLED STUDY; FRONTAL CORTEX; HEART RATE; HIPPOCAMPUS; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PREPIRIFORM CORTEX; PRIORITY JOURNAL; RAT; SENSORIMOTOR CORTEX;

ANIMALS; ARACHIDONIC ACIDS; AUTORADIOGRAPHY; BLOOD GAS ANALYSIS; CALCIUM CHANNEL BLOCKERS; CEREBROVASCULAR CIRCULATION; HEMODYNAMIC PROCESSES; MALE; POLYUNSATURATED ALKAMIDES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031782032     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(98)00043-8     Document Type: Article

References (66)

1. Bloom A.S., Tershner S., Fuller S.A., Stein E.A. Cannabinoid induced alterations in regional cerebral blood flow in the rat. Pharmacol Biochem Behav. 57:1997;625-631.
2. Busija D.W., Heistad D.D. Factors involved in the physiological regulation of the cerebral circulation. Rev Physiol Biochem Pharmacol. 101:1984;161-211.
3. Cador M., Robbins T.W., Everitt B.J. Involvement of the amygdala in stimulus-reward associations. interactions with the ventral striatum Neuroscience. 30:1989;77-86.
4. Chait L.D., Pierri J. Effects of smoked marijuana on human performance. A critical review Murphy L., Bartke A. Marijuana/Cannabinoids. Neurobiology and Neurophysiology:1992;387-423 CRC Press, Boca Raton.
5. 9-tetrahydrocannabinol enhances ventral tegmental somatodendritic dopamine levels but not forebrain dopamine levels. Evidence for local neural action by marijuana's psychoactive ingredient Brain Res. 621:1993;65-70.
6. 9-Tetrahydrocannabinol enhances presynaptic dompamine efflux in medial prefrontal cortex. Eur J Pharmacol. 190:1990;259-262.
7. Childers S.R., Sexton T., Roy M.B. Effects of anandamide on cannabinoid receptors in rat brain membranes. Biochem Pharmacol. 47:1994;711-715.
8. Compton DR, Harris LS, Lichtman AH, Martin BR (1996): Marihuana. In Schuster CR, Kuhar MJ (eds), Pharmacological Aspects of Drug Dependence: Toward an Integrated Neurobehavioral Approach, Handbook of Experimental Pharmacology. pp 83-158.
9. Crawley J.N., Corwin R.L., Robinson J.K., Felder C.C., Devane W.A., Axelrod J. Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. Pharmacol Biochem Behav. 46:1993;967-972.
10. Deutsch D.G., Chin S.A. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem Pharmacol. 46:1993;791-796.
11. Devane W., Axelrod J. Enzymatic synthesis of anandamide, and endogenous ligand for the cannabinoid receptor by brain membranes. Proc Natl Acad Sci USA. 91:1994;6698-6701.
12. Devane W.A., Dysarz F.A., Johnson M.R., Melvin L.S., Howlett A.C. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol. 34:1988;605-613.
13. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain consistent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949.
14. Dewey W.L. Cannabinoid pharmacology. Pharmacol Rev. 38:1986;151-178.
15. Ferri S., Costa G., Murari G., Panico A.M., Rapisaarda E., Speroni E., Arrigo-Reina R. Investigations on behavioral effects of an extract of Cannabis sativa L in the rat. Psychopharmacology. 75:1981;144.
16. Finch D.A. Hippocampal, subicular, and entorhinal afferents and synaptic integration in rodent cingulate cortex. Vogt B.A., Gabriel M. Neurobiology of the Cingulate Cortex and Limbic Thalamus. 1993;224-248 Birkhäuser, Boston.
17. Fride E., Mechoulam R. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur J Pharmacol. 231:1993;313-314.
18. Gardner E.L., Lowinson J.H. Marijuana's interaction with brain reward systems. Update 1991 Pharmacol Biochem Behav. 40:1991;571-580.
19. 9-tetrahydrocannabinol. Psychopharmacology. 96:1988;142-144.
20. Gloor P. Electrophysiological studies of the amygdala (stimulation and recording). Their possible contributions to the understanding of neural mechanisms of aggression Fields W.S., Sweet W.H. Neural Basis of Violence and Aggression. 1975;5-40 Warren O. Green, St. Louis, MO.
21. Gough A.L., Olley J.E. Catalepsy induced by intrastriatal injections of delta-9-THC and 11 hydroxy-delta-9-THC in the rat. Neuropharmacology. 17:1978;137-144.
22. Herkenham M., Groen B.G.S., Lynn A.B., Decosta B.R., Richfield E.K. Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum. Brain Res. 552:1991;301-310. a.
23. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain. A quantitative in vitro autoradiographic study J Neurosci. 11:1991;563-583. b.
24. 9-tetrahydrocannabinol on delayed match to sample performance in rats. Alterations in short-term memory associated with changes in task specific firing of hippocampal cells J Pharmacol Exp Ther. 264:1993;294-307.
25. Hillard C.J., Edgemond W.S., Campbell W.B. Characterization of ligand binding to the cannabinoid receptor of rat brain membranes using an novel method. Application to anandamide J Neurochem. 64:1995;677-683.
26. Howlett A.C., Bidaut-Russell M., Devane W.A., Melvin L.S., Johnson M.R., Herkenham M. The cannabinoid receptor. Biochemical, anatomical, and behavioral characterization TINS. 13:1990;420-423.
27. Jansen E.M., Haycock D.A., Ward S.J., Seybold V.S. Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles. Brain Res. 575:1992;93-102.
28. 14C]iodoantipyrine in the mouse. J Cereb Blood Flow Metab. 8:1988;121-129.
29. Kelley A.E., Domesick V.B., Nauta W.J.H. The amygdalostriatal projection in the rat - An anatomical study by anterograde and retrograde methods. Neuroscience. 7:1982;615-630.
30. Krettek J.E., Price J.L. Projections from the amygdaloid complex to the cerebral cortex and thalamus in the rat and cat. J Comp Neurol. 172:1977;687-722.
31. Lichtman A.H., Martin B.R. Spinal and supraspinal mechanisms of cannabinoid-induced antinociception. J Pharmacol Exp Ther. 258:1991;517-523.
32. Lichtman A.H., Dimen K.R., Martin B.R. Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology. 119:1995;282-290.
33. Mackie K., Hille B. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci USA. 89:1992;3825-3829.
34. 9-Tetrahydrocannabinol alters cerebral metabolism in a biphasic, dose-dependent manner in rat brain. Eur J Pharmacol. 202:1991;373-378.
35. Martin W.J., Lai N.K., Patrick S.L., Tsou K., Walker J.M. Antinociceptive actions of cannabinoids following intraventricular administration in rats. Brain Res. 629:1993;300-304.
36. Mathew R.J., Wilson W.H. Acute changes in cerebral blood flow after smoking marijuana. Life Sci. 52:1993;757-767.
37. Mathew R.J., Wilson W.H., Tant S.R. Acute changes in cerebral blood flow associated with marijuana smoking. Acta Psychiat Scand. 79:1989;108-128.
38. Mathew R.J., Wilson W.H., Humphreys D.F., Lowe J.V., Wiethe K.E. Regional cerebral blood flow after marijuana smoking. J Cereb Blood Flow Metab. 12:1992;750-758.
39. Matsuda L.A., Bonner T.I., Lolait S.J. Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol. 327:1993;535-550.
40. Mogenson G.J., Jones D.L., Yim C.Y. From motivation to action. Functional interface between the limbic system and the motor system Prog Neurobiol. 14:1980;69-97.
41. Moskowitz H. Marihuana and driving. Accid Annal Prevent. 17:1985;323-345.
42. 9-tetrahydrocannabinol and codeine. Clin Pharmacol Ther. 18:1975;84-89.
43. O'Keefe J. A review of hippocampal place cells. Prog Neurobiol. 13:1979;419-439.
44. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 4:1986;Academic Press, New York.
45. Pertwee R.G. The ring test. A quantitative method for assessing the "cataleptic" effects of cannabis in mice Brit J Pharmacol. 46:1972;753-763.
46. Pertwee R.G., Wickens A.P. Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids. Neuropharmacology. 30:1991;237-244.
47. Pertwee R.G. The central neuropharmacology of psychotropic cannabinoids. Pharmac Ther. 36:1988;189-261.
48. Porrino L.J., Domer F.R., Crane A.M., Sokoloff L. Selective alterations in cerebral metabolism within the mesocorticolimbic dopaminergic system produced by acute cocaine administration in the rat. Neuropsychopharmacology. 1:1988;109-118.
49. 14C]antipyrine. Am J Physiol. 234:1978;H59-H66.
50. Schwartz R.H. Chronic marihuana smoking and short-term memory impairment. Nahas G.C., Latour C. Cannabis. Physiopathology, Epidemiology, Detection:1993;61-71 CRC Press, Boca Raton.
51. 9-tetrahydrocannabinol-induced analgesia. Brain Res. 578:1992;8-12.
52. Smith P.B., Compton D.R., Welch S.P., Razdan R.K., Mechoulam R., Martin B.R. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J Pharmacol Exp Ther. 270:1994;219-227.
53. Sokoloff L. Relationships among local functional activity, energy metabolism, and blood flow in the central nervous system. Fed Proc. 40:1981;2311-2316.
54. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization. Theory, procedure, and normal values in the conscious and anesthetized albino rat J Neurochem. 28:1977;897-916.
55. Squire L.R. Memory. Neural organiztion and behavior Mountcastle V., Plum F., Geigner S.R. Handbook of Physiology - The Nervous System. 1987;American Physiological Society, Bethesda, MD.
56. Stein E.A., Fuller S.A. Selective effects of cocaine on regional cerebral blood flow in the rat. J Pharmacol Exper Therapeu. 262:1992;327-334.
57. Stein E.A., Fuller S.A., Edgemond W.S., Campbell W.B. Physiological and behavioral effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat. Brit J Pharmacol. 119:1996;107-114.
58. Swanson L.W. A direct projection from Amman's horn to prefrontal cortex in the rat. Brain Res. 217:1981;150-154.
59. 9-THC-DMH. J Pharmacol Exp Ther. 263:1992;1383-1390.
60. Trusk T.C., Stein E.A. Effect of intravenous heroin and naloxone on regional cerebral blood flow in the conscious rat. Brain Res. 406:1987;238-245.
61. Varga K., Lake K.J., Martin B.R., Kunos G. Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. Eur J Pharmacol. 278:1995;279-283.
62. Vogel Z., Barg J., Levy R., Saya D., Heldman E., Mechoulam R. Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J Neurochem. 61:1993;352-355.
63. Volkow N.D., Gillespie H., Mullani N., Tancredi L., Grant C., Ivanovic M., Hollister L. Cerebellar metabolic activation by delta-9-tetrahydrocannabinol in human brain. A study with positron emission tomography and 18F-2-fluoro-2-deoxyglucose Psychia Res. 40:1991;69-78.
64. Volkow N.D., Gillespie H., Mullani N., Tancredi L., Grant C., Valentine A., Hollister L. Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication. Psychia Res. 67:1996;29-38.
65. Welch S.P., Thomas C., Patrick G.S. Modulation of cannabinoid-induced antiociception following intracerebroventricular versus intrathecal administration to mice. possible mechanisms for interaction with morphine J Pharmacol Exp Ther. 272:1994;310-331.
66. Wise R.A., Rompre P.-P. Brain dopamine and reward. Ann Rev Psychol. 40:1989;191-225.